Seegnal prescription platform used by Israeli hospital

Executive Summary

• Seegnal Inc. has expanded its deployment of its prescription intelligence platform at Tel Aviv Sourasky Medical Center, Israel's second-largest public hospital, effective January 1, 2026.
• The expanded agreement runs through December 31, 2027, with an option to extend through December 31, 2031, covering approximately 1,200 clinicians and 2,050 medical team members.
• The deployment serves as a global reference model for large-scale clinical decision support, with the hospital actively presenting the implementation to international medical centers.

Key Details

• Parties: Seegnal Inc. and Tel Aviv Sourasky Medical Center (a leading Israeli public medical center and global referral center treating over 1.5 million patients annually).
• Deployment Scope: The platform supports approximately 1,200 clinicians and 2,050 medical team members, integrated into daily routine clinical workflows.
• Contract Duration: Effective January 1, 2026, through December 31, 2027, with an option to extend through December 31, 2031.
• Technical Integration: Seegnal’s SaaS-based platform provides real-time, patient-specific medication decision support at the point of care, integrating data such as laboratory results, co-morbidities, age, renal function, and polypharmacy context.
• Operational Impact: The system aims to maintain clinical efficiency, minimize alert fatigue, and establish a consistent patient-centric medication safety standard across inpatient and outpatient settings.
• Strategic Value: Sourasky Medical Center serves as an active reference site, supporting peer medical centers worldwide and evaluating modern approaches to medication safety and prescribing governance.
• Market Validation: The deployment reinforces Seegnal’s position as a standard of care system for over 15,000 clinicians in Israel, following the adoption of its patient-specific standard by the Israeli Ministry of Health in governmental hospitals.

Notable Quotes

• "Sourasky Medical Center represents one of the most advanced clinical environments within public health systems worldwide. The expansion of our deployment reflects strong confidence in the clinical, operational and economic value Seegnal delivers at scale." — Elad Bibi-Aviv, CEO of Seegnal
• "Sourasky Medical Center's role as a global reference site further validates our platform's maturity and scalability. This deployment demonstrates that patient-specific prescribing intelligence can improve safety and efficiency while supporting sustainable economics for large medical centers." — Elad Bibi-Aviv, CEO of Seegnal